Literature DB >> 19657023

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.

Davide Tampellini1, Nawreen Rahman, Eduardo F Gallo, Zhenyong Huang, Magali Dumont, Estibaliz Capetillo-Zarate, Tao Ma, Rong Zheng, Bao Lu, David M Nanus, Michael T Lin, Gunnar K Gouras.   

Abstract

A central question in Alzheimer's disease research is what role synaptic activity plays in the disease process. Synaptic activity has been shown to induce beta-amyloid peptide release into the extracellular space, and extracellular beta-amyloid has been shown to be toxic to synapses. We now provide evidence that the well established synaptotoxicity of extracellular beta-amyloid requires gamma-secretase processing of amyloid precursor protein. Recent evidence supports an important role for intraneuronal beta-amyloid in the pathogenesis of Alzheimer's disease. We show that synaptic activity reduces intraneuronal beta-amyloid and protects against beta-amyloid-related synaptic alterations. We demonstrate that synaptic activity promotes the transport of the amyloid precursor protein to synapses using live cell imaging, and that the protease neprilysin is involved in reduction of intraneuronal beta-amyloid with synaptic activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657023      PMCID: PMC2763626          DOI: 10.1523/JNEUROSCI.2292-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

Authors:  John R Cirrito; Jae-Eun Kang; Jiyeon Lee; Floy R Stewart; Deborah K Verges; Luz M Silverio; Guojun Bu; Steven Mennerick; David M Holtzman
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

2.  Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.

Authors:  Lawrence Rajendran; Anja Schneider; Georg Schlechtingen; Sebastian Weidlich; Jonas Ries; Tobias Braxmeier; Petra Schwille; Jörg B Schulz; Cornelia Schroeder; Mikael Simons; Gary Jennings; Hans-Joachim Knölker; Kai Simons
Journal:  Science       Date:  2008-04-25       Impact factor: 47.728

3.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

4.  Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity.

Authors:  Zhiping Wang; Jeffrey G Edwards; Nathan Riley; D William Provance; Ryan Karcher; Xiang-Dong Li; Ian G Davison; Mitsuo Ikebe; John A Mercer; Julie A Kauer; Michael D Ehlers
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

5.  Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.

Authors:  Haim Belinson; Dimitri Lev; Eliezer Masliah; Daniel M Michaelson
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

6.  Amyloid beta mediates memory formation.

Authors:  Ana Garcia-Osta; Cristina M Alberini
Journal:  Learn Mem       Date:  2009-03-24       Impact factor: 2.460

7.  Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Authors:  Daniela Puzzo; Lucia Privitera; Elena Leznik; Mauro Fà; Agnieszka Staniszewski; Agostino Palmeri; Ottavio Arancio
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

8.  Amyloid-beta dynamics correlate with neurological status in the injured human brain.

Authors:  David L Brody; Sandra Magnoni; Kate E Schwetye; Michael L Spinner; Thomas J Esparza; Nino Stocchetti; Gregory J Zipfel; David M Holtzman
Journal:  Science       Date:  2008-08-29       Impact factor: 47.728

9.  A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.

Authors:  Atul Deshpande; Hideki Kawai; Raju Metherate; Charles G Glabe; Jorge Busciglio
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.

Authors:  Melanie Meyer-Luehmann; Tara L Spires-Jones; Claudia Prada; Monica Garcia-Alloza; Alix de Calignon; Anete Rozkalne; Jessica Koenigsknecht-Talboo; David M Holtzman; Brian J Bacskai; Bradley T Hyman
Journal:  Nature       Date:  2008-02-07       Impact factor: 49.962

View more
  63 in total

Review 1.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

Authors:  Dimitrios Kapogiannis; Mark P Mattson
Journal:  Lancet Neurol       Date:  2010-12-10       Impact factor: 44.182

2.  Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice.

Authors:  Davide Tampellini; Estibaliz Capetillo-Zarate; Magali Dumont; Zhenyong Huang; Fangmin Yu; Michael T Lin; Gunnar K Gouras
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

3.  Critical role of intraneuronal Aβ in Alzheimer's disease: technical challenges in studying intracellular Aβ.

Authors:  Gunnar K Gouras; Katarina Willén; Davide Tampellini
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

4.  Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.

Authors:  Sam Gandy; Adam J Simon; John W Steele; Alex L Lublin; James J Lah; Lary C Walker; Allan I Levey; Grant A Krafft; Efrat Levy; Frédéric Checler; Charles Glabe; Warren B Bilker; Ted Abel; James Schmeidler; Michelle E Ehrlich
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

Review 5.  Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.

Authors:  Seung-Jae Lee; Hee-Sun Lim; Eliezer Masliah; He-Jin Lee
Journal:  Neurosci Res       Date:  2011-05-20       Impact factor: 3.304

6.  FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Authors:  Jaehong Suh; Alvin Lyckman; Lirong Wang; Elizabeth A Eckman; Suzanne Y Guénette
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

7.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

8.  Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions.

Authors:  Xuejing Li; Kengo Uemura; Tadafumi Hashimoto; Navine Nasser-Ghodsi; Muriel Arimon; Christina M Lill; Isabella Palazzolo; Dimitri Krainc; Bradley T Hyman; Oksana Berezovska
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

9.  Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.

Authors:  Davide Tampellini; Gunnar K Gouras
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

10.  Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo.

Authors:  John W Steele; Soong H Kim; John R Cirrito; Deborah K Verges; Jessica L Restivo; David Westaway; Paul Fraser; Peter St George Hyslop; Mary Sano; Ilya Bezprozvanny; Michelle E Ehrlich; David M Holtzman; Sam Gandy
Journal:  Mol Neurodegener       Date:  2009-12-17       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.